LEADER 03698nam  2200637Ia 450 
001 9910807920803321
005 20200520144314.0
010   $a1-283-58878-1
010   $a9786613901231
010   $a1-78190-129-5
035   $a(CKB)2560000000093110
035   $a(EBL)1019357
035   $a(OCoLC)809314304
035   $a(SSID)ssj0000740846
035   $a(PQKBManifestationID)11470122
035   $a(PQKBTitleCode)TC0000740846
035   $a(PQKBWorkID)10701205
035   $a(PQKB)10538138
035   $a(MiAaPQ)EBC1019357
035   $a(Au-PeEL)EBL1019357
035   $a(CaPaEBR)ebr10597036
035   $a(CaONFJC)MIL390123
035   $a(OCoLC)811577735
035   $a(UtOrBLW)bslw08837371
035   $a(EXLCZ)992560000000093110
100   $a20120916d2012      uy         0
101 0 $aeng
135   $aurun|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aAdvances in health economics and health services research$hVolume 23$iThe economics of medical technology /$fedited by Kristian Bolin, Robert Kaestner
205   $a1st ed.
210   $aBingley, U.K. $cEmerald$d2012
215   $a1 online resource (211 p.)
225 0 $aAdvances in health economics and health services research ;$vv. 23
300   $aDescription based upon print version of record.
311   $a1-78190-128-7 
320   $aIncludes bibliographical references.
327   $aOverview / Kristian Bolin, Robert Kaestner -- Aspects of research and development contract terms in the bio/pharmaceutical sector / Tannista Banerjee -- Effects of regulation on drug launch and pricing in interdependent markets / Patricia M. Danzon, Andrew J. Epstein -- The effect of pharmaceutical innovation on the functional limitations of elderly Americans : evidence from the 2004 National Nursing Home Survey / Frank R. Lichtenberg -- Comparative effectiveness research, technological abandonment, and health care spending / David H. Howard, Yu-Chu Shen -- How do initial signals of quality influence the diffusion of new medical products? : the case of new cancer drug treatments / Rena M. Conti, Arielle Bernstein, David O. Meltzer -- Technology diffusion and substitution of medical innovations / Victoria Serra-Sastre, Alistair McGuire -- Health insurance and hospital technology adoption / Seth Freedman.
330   $aMedical technology broadly defined to include all aspects of the process of treating disease (e.g., pharmaceuticals, medical devices, and surgical procedures) is profoundly important for individual health and, consequently, also for general welfare. Advances in medical technology convey the prospect of both improved population health and increased general welfare. However, because of the extensive regulation of the markets for healthcare goods and services, the development and application of medical technologies differs fundamentally from non-medical technological advances. In this volume of the Advances in Health Economics and Health Services Research series we present several papers that provide theoretical and empirical evidence about the market for medical technology.
410  0$aAdvances in health economics and health services research ;$vv. 23.
606   $aMedical economics
606   $aMedical economics$zUnited States
615  0$aMedical economics.
615  0$aMedical economics
676   $a338.4361028
701   $aBolin$b Krstian$01753095
701   $aKaestner$b Robert$01656943
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910807920803321
996   $aAdvances in health economics and health services research$94188666
997   $aUNINA